1. Home
  2. HBB vs TLSI Comparison

HBB vs TLSI Comparison

Compare HBB & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hamilton Beach Brands Holding Company

HBB

Hamilton Beach Brands Holding Company

HOLD

Current Price

$20.32

Market Cap

252.9M

ML Signal

HOLD

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$3.76

Market Cap

270.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBB
TLSI
Founded
1904
2010
Country
United States
United States
Employees
N/A
102
Industry
Home Furnishings
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
252.9M
270.2M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
HBB
TLSI
Price
$20.32
$3.76
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
14.9K
481.2K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
2.38%
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$606,852,000.00
N/A
Revenue This Year
N/A
$35.45
Revenue Next Year
N/A
$37.58
P/E Ratio
$77.81
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.72
$2.20
52 Week High
$21.84
$7.95

Technical Indicators

Market Signals
Indicator
HBB
TLSI
Relative Strength Index (RSI) 55.39 54.52
Support Level $17.90 $3.70
Resistance Level $20.57 $4.79
Average True Range (ATR) 0.89 0.27
MACD 0.08 0.09
Stochastic Oscillator 75.53 87.81

Price Performance

Historical Comparison
HBB
TLSI

About HBB Hamilton Beach Brands Holding Company

Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products segment includes consumer product revenue consisting of sales of small electric household and specialty housewares appliances whereas the health segment includes lease revenue associated with leases of connected devices to specialty pharmacy networks and pharmaceutical companies, as well as licensing revenue which grant customers the right to use software for healthcare management.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

Share on Social Networks: